Glenn Chamandy, Gildan Activewear’s co-founder. PHOTO: RYAN REMIORZ/ASSOCIATED PRESS CorpGov hosted a fireside chat with Jonathan Feldman, Partner and Head of Shareholder Activism Practice at Goodmans LLP,joined by Editor-at-Large Jarrett Banks. They discussed activist investor Browning West’s landmark victory in its proxy campaign against Gildan Activewear Inc. (TSX and NYSE: GIL), the reasons why the board’s tactics failed and the possible implications for other activist situations, and more. Watch the full recording below: AboutGoodmans LLP Goodmans LLP is internationally recognized as one of Canada’s leading law firms for M&A, capital markets, securities and finance, private equity, real estate, tax, restructuring, dispute resolution, and other business-related specialties. Our clients are business leaders, innovators, entrepreneurs, and investors who need counsel from a law firm that is as enterprising, forward-thinking and direct as they are. We work hard to develop the most appropriate solution for any situation and provide clear, concise, and straightforward advice to solve some of their most complex and demanding legal issues. About Jonathan Feldman Jon Feldman is a partner and heads a business law group at Goodmans. His practice focuses on corporate and securities law with an emphasis on mergers and acquisitions (M&A). Jon has extensive experience acting for buyers and sellers in a wide range of industries in both private and public M&A transactions. Jon’s market leading practice in Canada in the area of shareholder activism is highlighted by his involvement in a number of the most high profile proxy contests representing both dissident shareholders and boards of directors. Jon also provides strategic advice in litigation matters requiring corporate and securities law knowledge. Before joining Goodmans in 2004, Jon was an associate in the M&A Group of White & Case LLP in New York, where he represented clients in a broad range of M&A transactions. Jon is consistently recognized as a leading lawyer by publications including: Chambers Canada (corporate/commercial – Ontario), The Legal 500 Canada (corporate M&A), IFLR1000 (M&A), Euromoney’s Banking, finance and transaction Expert Guide (M&A), The Canadian Legal Lexpert Directory (M&A, private equity and corporate finance & securities), The Lexpert/ALM Guide to the Leading 500 Lawyers in Canada (M&A), and Best Lawyers in Canada (corporate governance, M&A, corporate, leveraged buyouts and private equity). He was recently featured in the Lexpert Special Edition: Finance and M&A 2023. Jon has also been honoured as one of Lexpert’s Rising Stars: Leading Lawyers Under 40. Contact: CorpGov.com [email protected] The post Goodmans’ Feldman on Implications of Proxy Campaign Victory Against Gildan appeared first on CorpGov.
Goodmans’ Feldman on Implications of Proxy Campaign Victory Against Gildan
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...